Ronald L. Goode, Senior Industry Advisor, Biotechnology and Pharmaceuticals, has decades of global experience as a scientist and senior executive in the biotechnology and pharmaceuticals industry. Dr. Goode taps his considerable knowledge and expertise on behalf of Kinsella Group and our clients, advising on the formation of international alliances, developing joint ventures, and other key corporate transactions in the field of healthcare products and services.

Dr. Goode has served in key leadership roles in a number of well-known and cutting-edge pharmaceutical companies. He has held senior management positions at Pfizer Pharmaceuticals, including Vice President of Clinical Research and Scientific Affairs, and Director of Marketing Research, among other responsibilities. At G.D. Searle & Co., he served as Senior Vice President of Commercial Development, President of Asia/Pacific World Area, and President of Searle International.

For these companies, Dr. Goode has supervised clinical development programs that led to the filing of over a dozen New Drug Approval applications, including Pfizer's Procardia XL® and Searle's Ambien®. During this period, he also developed an extensive record of successful business development, having been responsible for many of Searle's acquisitions, including DayPro®, which became Searle's largest-selling drug.

Dr. Goode has served as President and Chief Executive Officer of two public companies, Unimed Pharmaceuticals, Inc. and eXegenics Inc. He also served as a Director of Unimed until the company was sold to Solvay Et Cie, the Belgium-based conglomerate, and on the Board of Directors of eXegenics, the final year of which he also served as Chairman.

In addition to these leadership positions, Dr. Goode served as a Director for a number of other public companies, including Vitro Diagnostics, Inc. (a Nevada-based company) and Hokuriku Seiyaku (in which he was the only non-Japanese Director for this publicly held Japanese pharmaceutical company). He presently serves on the Board of Directors of Genitope (Nasdaq: GTOP) and the Advisory Boards of ART Recherchés et Technologies Avancées Inc. (Toronto: ARI) and Greystone Pharmaceutical Group.

Recently, he formed his own consulting company (dba "The Goode Group") with the mission of creating "links" between pharmaceutical companies to help them devise alliances, form joint ventures and implement various transactions. Under Sarbanes-Oxley, Dr. Goode is also qualified to serve as an "Audit Committee Financial Expert."

Throughout his service in these various roles, Dr. Goode has developed broad expertise in global business operations, including full P&L responsibility, product development, launch and marketing, business development, mergers and acquisitions, financial operations and financing. He also has significant experience in managing class action lawsuits, proxy fights, D&O insurance issues, NASDAQ listing issues, and the like.

In 2000 Dr. Goode and his wife, Sheila, spent a sabbatical with his charity of choice, Mercy Ships International. Among the non-profit Boards of Directors/Trustees on which he serves are Mercy Ships and Thunderbird, The Garvin Graduate School of International Management. Dr. Goode received his Ph.D. in Microbial Genetics from the University of Georgia.



Elizabeth Harrington, Senior Advisor, China, brings nearly 25 years of experience in China and Asia to Kinsella Group. As a corporate director, senior corporate executive, entrepreneur and management consultant, Ms. Harrington has a strong record of increasing growth, profit and competitive advantage through innovative strategies and effective implementation in the global consumer products, retail, healthcare and industrial products industries.

As Chief Executive Officer of Harrington Global, a global management-consulting firm specializing in China and Asia, Ms. Harrington is a respected advisor to the government of the People's Republic of China, among other major clients. In this capacity, she provides guidance with regard to the modernization and global expansion of China's retail, distribution, entertainment, garment and automobile industries.

Working with the Chinese government, domestic Chinese companies and businesses around the world - including the United States and Europe - Ms. Harrington assists with cross-border acquisitions, joint ventures, investments and other transactions, advises on management systems and training issues, and enables foreign companies to enter and improve their business operations and performance throughout China and Asia.

Prior to founding Harrington Global, Ms. Harrington served in key leadership roles in a number of well-known consumer-products and management-consulting companies. As a Partner in the Global Strategic Change Practice of PricewaterhouseCoopers, she led numerous clients through the development of strategic initiatives to their final implementation throughout the United States, China and Asia. These initiatives included restructuring pharmaceutical joint ventures, developing e-commerce business systems, modernizing operations and attracting foreign investment.

As Vice President of Marketing Development-Green Giant Group for the Pillsbury Company, Ms. Harrington was responsible for accelerating earnings growth through strategic planning, acquisitions, joint ventures, new-product development and global brand expansion in Asia, Latin America and the Middle East. As a Partner and Director of the Worldwide Consumer Products Strategy Practice of A.T. Kearney, she led the strategic analysis, business planning, integrated marketing and implementation of a number of consumer-products initiatives, both internally and for external clients.

Ms. Harrington also has a strong background in advertising and marketing. As Chief Executive Officer and co-owner of the Don Tennant Company, Vice President of Marketing Services for the Quaker Oats Company (and President of its in-house advertising agency, AdCom), and Vice President and Managing Director of the J. Walter Thompson Company, she has helped these business and their clients improve growth and profitability, increase market share and visibility, streamline operations, raise productivity, develop value-added services, and roll out marketing programs that maximize investments in products and strategic initiatives. In these roles, she has also led the successful turnaround of numerous failing divisions and subsidiary businesses.

Ms. Harrington's clients include some of the best-known brands and companies worldwide, such as AT&T, Bristol Myers Squibb, Dairy Farm/Jardine Group, Disney, JohnsonDiversey, Kimberly Clark, Kodak, Kraft, Lotte/Japan, M&M Mars, Nestlé, Oscar Mayer, Pilsbury, Proctor & Gamble, Quaker Oats, Ralston Purina, Sara Lee, S.C. Johnson, Sears, Sunbeam and Unilever.

In addition to her management and business-consulting work, Ms. Harrington has served - and continues to serve - as a director of numerous companies and organizations. She currently sits on the Boards of Directors of the Chicago Mercantile Exchange, the American Advertising Federation, the Better Business Bureau, Metropolitan Family Services of Chicago, Cornell University's President's Council, and the Mayor of Chicago's Shanghai Sister Cities Commission.

Ms. Harrington has been elected Advertising Woman of the Year and Marketing Executive of the Year. She is a regular contributor to industry and professional journals such as Corporate Board and Advertising Age, has written articles for the Conference Board, and is a frequent speaker at conferences and professional seminars dealing with China/Asia trade and global business strategies.

Ms. Harrington graduated magna cum laude and Phi Beta Kappa from Cornell University. She speaks French, Spanish and some Chinese.



Alan Rauh Orschel, Senior Advisor, draws on his vast experience in the fields of law, commerce and community service to assist Kinsella Group in a broad range of business development activities. Mr. Orschel couples his in-depth knowledge of banking and corporate transactions (including mergers and acquisitions) with his strong network of business and governmental contacts to help Kinsella Group foster relationships with the mid-market commercial banking and finance industries throughout the Midwest.

A practicing attorney for more than 40 years, Mr. Orschel was a partner in the Chicago-area law firm of Crowley, Barrett and Karaba Ltd. He served as Senior Partner and Co-Managing Partner, and during his tenure, Mr. Orschel helped triple the size of the 80-year old firm. In his own practice, he regularly advised businesses and individuals on a broad range of legal and commercial matters, from securities, banking, real estate and family law to litigation and corporate law (including mergers, acquisitions and divestitures). Mr. Orschel has particular experience working with distressed businesses, including foreclosures, workouts, bankruptcies, restructurings, sales and third-party asset purchases.

Mr. Orschel participated in the Chicago-area legal, business and civic communities. He is a member of the American Bar Association, the Illinois Bar Association and the Chicago Bar Association. For almost a decade, Mr. Orschel provided pro bono legal services to residents of the Cabrini Green Housing Project in Chicago.

As a longtime member of the Economic Club of Chicago, Mr. Orschel has served on a number of the organization's committees. For eight years, he served as a member of the School Board of St. Francis Xavier School in Wilmette, Illinois, including two years of service as President of the Board. Mr. Orschel was a Director of the Bureau on Jewish Employment Problems for 30 years, and President of the organization for two years. Mr. Orschel has been an active fundraiser for - and leader of - numerous charitable and alumni institutions for more than four decades.

Mr. Orschel earned his law degree from the University of Chicago Law School, where he served as Student Body President. After law school, he clerked for an Illinois Appellate Court Judge. He earned his undergraduate degree, cum laude, from Dartmouth College.